News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Conference News PCR London Valves 2020 Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND Michael O'Riordan November 25, 2020
News Conference News ACC 2020 PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery Yael L. Maxwell March 31, 2020
News Conference News VIVA 2019 Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’ L.A. McKeown November 07, 2019
News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018
News Conference News PCR London Valves 2017 TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis Shelley Wood September 24, 2017
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Conference News EuroPCR 2016 Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up Shelley Wood May 20, 2016
News Conference News EuroPCR 2016 No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests Michael O'Riordan May 19, 2016
News Conference News EuroPCR 2016 LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016
News Conference News TCT 2014 Lively Debate on Use of TAVR for Lower-Risk Patients September 14, 2014
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013